Spring is Here and Medicare Advantage is in Full Bloom

MCOL Staff, April 7, 2022

Mark Farrah Associates has released their assessment of Medicare Advantage  and Prescription Drug Plan  performance, market share and market penetration as of March, 2022. They report that total MA membership exceeded 29.4 million and Medicare stand-alone PDPs covered over 23.4 million members. Year-over-year MA plan enrollment grew by 8.5%, and PDPs experienced a membership decrease of -3.4%.

MFA tells us that:

• Texas experienced the most sizeable year-over-year increase of over 172,000 MA members.
• Stand-alone PDPs continued to see a significant decrease of approximately 824,000 enrollees between March 1, 2021 and March 1, 2022.
• CVS, Centene, UnitedHealth, Humana and Cigna were the top five companies that dominate 88.5% of the PDP market.

MFA reports that In the MA world, UnitedHealth in March 2022 holds the top position with 27.1% marketshare, followed by Humana with 17.4%, CVS Health with 10.7%, Anthem with 6.5% and Kaiser with 6.1%.

Also, here’s the March 2022 MA/PDP Snapshot recently released by MCOL in HealthExecSnapshot: